Hcw Biologics Inc (HCWB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,568 | -2,057 | -12,863 | -9,689 | -5,594 |
| Depreciation Amortization | 292 | 143 | 544 | 436 | 314 |
| Accounts receivable | -214 | -420 | 2,367 | 2,430 | 2,450 |
| Other Working Capital | 252 | -123 | 1,455 | 2,209 | 3,358 |
| Other Operating Activity | 956 | 866 | -2,479 | -2,985 | -3,007 |
| Operating Cash Flow | $-4,282 | $-1,592 | $-10,976 | $-7,599 | $-2,480 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 8,000 | 8,000 | -24,987 | -24,990 | N/A |
| PPE Investments | -37 | -24 | -47 | -27 | -23 |
| Purchase Of Investment | N/A | N/A | -9,984 | -9,978 | N/A |
| Investing Cash Flow | $7,963 | $7,976 | $-35,019 | $-34,995 | $-23 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 8 | 2 | 30 | 23 | 23 |
| Other Financing Activity | 0 | 0 | 49,240 | 49,240 | -924 |
| Financing Cash Flow | $8 | $2 | $49,270 | $49,263 | $-902 |
| Beginning Cash Position | 11,731 | 11,731 | 8,456 | 8,456 | 8,456 |
| End Cash Position | 15,420 | 18,117 | 11,731 | 15,125 | 5,051 |
| Net Cash Flow | $3,690 | $6,386 | $3,275 | $6,669 | $-3,405 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,282 | -1,592 | -10,976 | -7,599 | -2,480 |
| Capital Expenditure | -37 | -24 | -47 | -27 | -23 |
| Free Cash Flow | -4,319 | -1,616 | -11,023 | -7,627 | -2,504 |